| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Mechanisms of oxysterol-induced carcinogenesis. | Jusakul, A. Yongvanit, P. Loilome, W. Namwat, N. |
2011 | ||||
| 2. | Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: A potential molecular marker for tumor metastasis | Loilome, W Wechagama, P Namwat, N Jusakul, A Sripa, B Miwa, M Kuver, R Yongvanit, P |
2012 | ||||
| 3. | Identification of Biliary Bile Acids in Patients with Benign Biliary Diseases, Hepatocellular Carcinoma and Cholangiocarcinoma | Jusakul, A Khuntikeo, N Haigh, WG Kuver, R Ioannou, GN Loilome, W Namwat, N Bhudhisawasdi, V Pugkhem, A Pairojkul, C Yongvanit, P |
2012 | ||||
| 4. | Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes | Jusakul, A. Loilome, W. Namwat, N. Dechakhamphu, S. Sukontawarin, P. Pinlaor, S. Lee, S.P. Yongvanit, P. |
2012 | ||||
| 5. | Anti-apoptotic phenotypes of cholestan-3 beta,5 alpha,6 beta-triol-resistant human cholangiocytes: Characteristics contributing to the genesis of cholangiocarcinoma | Jusakul, A. Loilome, W. Namwat, N. Techasen, A. Ioannou, G.N. Yongvanit, P. |
2013 | ||||
| 6. | Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers | Chan-On, W Nairismägi, ML Ong, CK Lim, WK Dima, S Pairojkul, C Lim, KH McPherson, JR Cutcutache, I Heng, HL Ooi, L Chung, A Chow, P Cheow, PC Lee, SY Choo, SP Tan, IB Duda, D Nastase, A Myint, SS Wong, BH Gan, A Rajasegaran, V Ng, CC Nagarajan, S Jusakul, A Zhang, S Vohra, P Yu, W Huang, D Sithithaworn, P Yongvanit, P Wongkham, S Khuntikeo, N Bhudhisawasdi, V Popescu, I Rozen, SG Tan, P Teh, BT |
2013 | ||||
| 7. | Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression. | Chakkaphan Khenjanta Raynoo Thanan Apinya Jusakul Anchalee Techasen Wassana Jamnongkan Nisana Namwat Watcharin Loilome Chawalit Pairojkul Puangrat Yongvanit |
2014 | ||||
| 8. | Genetics of Opisthorchis viverrini-related cholangiocarcinoma. | Apinya Jusakul Sarinya Kongpetch Bin Tean Teh |
2015 | ||||
| 9. | Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways | Sarinya Kongpetch Apinya Jusakul Choon Kiat Ong Weng Khong Lim Steven G. Rozen Patrick Tan Bin Tean Teh |
2015 | ||||
| 10. | Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma | Kern Rei Chng Sock Hoai Chan Amanda Hui Qi Ng Chenhao Li Apinya Jusakul Denis Bertrand Andreas Wilm Su Pin Choo Damien Meng Yew Tan Kiat Hon Lim Roy Soetinko Choon Kiat Ong Dan G. Duda Simona Dima Irinel Popescu Chaisiri Wongkham Zhu Feng Khay Guan Yeoh Bin Tean Teh Puangrat Yongvanit Sopit Wongkham Vajaraphongsa Bhudhisawasd Narong Khuntikeo Patrick Tan Chawalit Pairojkul Joanne Ngeow Niranjan Nagarajan |
2016 | ||||
| 11. | Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand | Senggunprai, L. Namwat, N. Kongpetch, S. Chamgramol, Y. Loilome, W. Khansaard, W. Jusakul, A. Prawan, A. Pairojkul, C. Yongvanit, P. Kukongviriyapan, V. |
2017 | ||||
| 12. | Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma. | Jusakul, A. Cutcutache, I. Kongpetch, S. Myint, S.S. Thanan, R. Ng, C.C.Y. Rajasegaran, V. McPherson, J.R. Khuntikeo, N. Bhudhisawasdi, V. Yongvanit, P. Dima, S.O.L. Shibata, T. Pairojkul, C. |
2017 | ||||
| 13. | TGF- beta 1: A Potential EMT-Biomarker for prediction of cholangiocarcinoma | Phongsaran Kimawaha Apinya Jusakul Puangrat Yongvanit Watcharin Loilome Nisana Namwat Narong Khuntikeo Anchalee Techasen |
2018 | ||||
| 14. | Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma | Apinya Jusakul Ioana Cutcutache Chern Han Yong Jing Quan Lim Mi Ni Huang Nisha Padmanabhan Vishwa Nellore Sarinya Kongpetch Alvin Wei Tian Ng Ley Moy Ng Su Pin Choo Swe Swe Myint Raynoo Thanan Sanjanaa Nagarajan Weng Khong Lim Cedric Chuan Young Ng Arnoud Boot Mo Liu Choon Kiat Ong Vikneswari Rajasegaran Stefanus Lie Alvin Soon Tiong Lim Tse Hui Lim Jing Tan Jia Liang Loh John R. McPherson Narong Khuntikeo Vajaraphongsa Bhudhisawasdi Puangrat Yongvanit Sopit Wongkham Yasushi Totoki Hiromi Nakamura Yasuhito Arai Satoshi Yamasaki Pierce Kah-Hoe Chow Alexander Yaw Fui Chung London Lucien Peng Jin Ooi Kiat Hon Lim Simona Dima Dan G. Duda Irinel Popescu Philippe Broet Sen-Yung Hsieh Ming-Chin Yu Aldo Scarpa Jiaming Lai Di-Xian Luo Andre Lopes Carvalho Andre Luiz Vettore Hyungjin Rhee Young Nyun Park Ludmil B. Alexandrov Raluca Gordan Steven G. Rozen Tatsuhiro Shibata Chawalit Pairojkul Bin Tean Teh Patrick Tan |
2018 | ||||
| 15. | Current omics-based biomarkers for cholangiocarcinoma. | Kitti Intuyod Napat Armartmuntree Apinya Jusakul Chadamas Sakonsinsiri Raynoo Thanan Somchai Pinlaor |
2019 | ||||
| 16. | A combination of monosodium glutamate and high-fat and high-fructose diets increases the risk of kidney injury, gut dysbiosis and host-microbial co-metabolism | Pongking, T Haonon, O Dangtakot, R Onsurathum, S Jusakul, A Intuyod, K Sangka, A Anutrakulchai, S Cha'on, U Pinlaor, S Pinlaor, P |
2020 | ||||
| 17. | alterations and their clinical significance in cholangiocarcinoma. | Namjan, A Techasen, A Loilome, W Sa-Ngaimwibool, P Jusakul, A |
2020 | ||||
| 18. | ARID1A alterations and their clinical significance in cholangiocarcinoma | Techasen, A. Loilome, W. Jusakul, A. |
2020 | ||||
| 19. | Circulating TGF-beta 1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma | Jusakul, A. Junsawang, P. Loilome, W. Khuntikeo, N. Techasen, A. |
2020 | ||||
| 20. | Enhancement of vitamin C on PMN function in healthy individuals | Laongthip Ruknarong Rujira Nonsa-ard Nisa Chuangchot Amonrat Jumnainsong Naruemon Leelayuwat Apinya Jusakul Chanvit Leelayuwat |
2020 | ||||
| 21. | Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma | Kongpetch, S Jusakul, A Lim, JQ Ng, CCY Chan, JY Rajasegaran, V Lim, TH Lim, KH Choo, SP Dima, S Popescu, I Duda, DG Kukongviriyapan, V Khuntikeo, N Pairojkul, C Rozen, SG Tan, P Teh, BT |
2020 | ||||
| 22. | Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma | Chanakankun, R Proungvitaya, T Chua-On, D Limpaiboon, T Roytrakul, S Jusakul, A Titapun, A Jarearnrat, A Proungvitaya, S |
2020 | ||||
| 23. | Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway | Janthamala, S Jusakul, A Kongpetch, S Kimawaha, P Klanrit, P Loilome, W Namwat, N Techasen, A |
2021 | ||||
| 24. | Concentration of urine samples improves sensitivity in detection of -specific IgG antibody in urine for diagnosis of strongyloidiasis. | Chungkanchana, N Sithithaworn, P Worasith, C Wongphutorn, P Ruantip, S Kopolrat, KY Jusakul, A Thanan, R Duenngai, K Sithithaworn, J Techasen, A |
2021 | ||||
| 25. | Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma | Preawwalee Wintachai Jing Quan Lim Anchalee Techasen Worachart Lert-Itthiporn Sarinya Kongpetch Watcharin Loilome Jarin Chindaprasirt Attapol Titapun Nisana Namwat Narong Khuntikeo Apinya Jusakul |
2021 | ||||
| 26. | Diagnostic and prognostic value of circulating cell‐free dna for cholangiocarcinoma | Wintachai, P. Techasen, A. Lert-Itthiporn, W. Kongpetch, S. Loilome, W. Titapun, A. Namwat, N. Khuntikeo, N. Jusakul, A. |
2021 | ||||
| 27. | Establishment of a potential serum biomarker panel for the diagnosis and prognosis of cholangiocarcinoma using decision tree algorithms | Phongsaran Kimawaha Apinya Jusakul Prem Junsawang Raynoo Thanan Attapol Titapun Narong Khuntikeo Anchalee Techasen |
2021 | ||||
| 28. | Promoter hypermethylation of early B cell factor 1 (EBF1) is associated with cholangiocarcinoma progression | Armartmuntree, N Jusakul, A Sakonsinsiri, C Loilome, W Pinlaor, S Ungarreevittaya, P Yong, CH Techasen, A Imtawil, K Kraiklang, R Suwannakul, N Kaewlert, W Chaiprasert, T Thanan, R Murata, M |
2021 | ||||
| 29. | Vitamin C supplementation reduces expression of circulating miR-451a in subjects with poorly controlled type 2 diabetes mellitus and high oxidative stress | Ruknarong, L Boonthongkaew, C Chuangchot, N Jumnainsong, A Leelayuwat, N Jusakul, A Gaudieri, S Leelayuwat, C |
2021 | ||||
| 30. | Concentration of Urine Samples Improves Sensitivity in Detection of Strongyloides-Specific IgG Antibody in Urine for Diagnosis of Strongyloidiasis | Sithithaworn, P. Worasith, C. Wongphutorn, P. Kopolrat, K.Y. Jusakul, A. Thanan, R. Duenngai, K. Sithithaworn, J. Techasen, A. |
2022 | ||||
| 31. | Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways. | Jaidee, R. Kukongviriyapan, V. Senggunprai, L. Prawan, A. Jusakul, A. Laphanuwat, P. Kongpetch, S. |
2022 | ||||
| 32. | Prediction of Angiopoietin-like Protein 4-related Signaling Pathways in Cholangiocarcinoma Cells. | Aung, T.M. Silsirivanit, A. Jusakul, A. Chan-On, W. Proungvitaya, T. Roytrakul, S. Proungvitaya, S. |
2022 | ||||
| 33. | Serum Angiopoietin-Like Protein 4: A Potential Prognostic Biomarker for Prediction of Vascular Invasion and Lymph Node Metastasis in Cholangiocarcinoma Patients | Aung, TM Ciin, MN Silsirivanit, A Jusakul, A Lert-Itthiporn, W Proungvitaya, T Roytrakul, S Proungvitaya, S |
2022 | ||||
| 34. | Therapeutic targeting of ARID1A and PI3K/AKT pathway alterations in cholangiocarcinoma. | Techasen, A. Kongpetch, S. Namjan, A. Loilome, W. Chan-On, W. Thanan, R. Jusakul, A. |
2022 | Count | 28 | 25 | 24 | 0 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | Total | ||||||
| 1. | Mechanisms of oxysterol-induced carcinogenesis | Jusakul, A. Yongvanit, P. Loilome, W. Namwat, N. |
2011 |
Lipids in Health and Disease (10), pp. |
||||||||
| 2. | Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: A potential molecular marker for tumor metastasis | Loilome, W. Wechagama, P. Namwat, N. Jusakul, A. Sripa, B. Miwa, M. Yongvanit, P. |
2012 |
Parasitology International 1 (61), pp. 136-139 |
||||||||
| 3. | Identification of biliary bile acids in patients with benign biliary diseases, hepatocellular carcinoma and cholangiocarcinoma | Jusakul, A. Khuntikeo, N. Ioannou, G.N. Loilome, W. Namwat, N. Bhudhisawasdi, V. Pugkhem, A. Pairojkul, C. Yongvanit, P. |
2012 |
Asian Pacific Journal of Cancer Prevention SUPPL.1 (13), pp. 77-82 |
||||||||
| 4. | Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes | Jusakul, A. Loilome, W. Namwat, N. Dechakhamphu, S. Sukontawarin, P. Pinlaor, S. Lee, S.P. Yongvanit, P. |
2012 |
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 1-2 (731), pp. 48-57 |
||||||||
| 5. | Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol- resistant human cholangiocytes: Characteristics contributing to the genesis of cholangiocarcinoma | Jusakul, A. Loilome, W. Namwat, N. Techasen, A. Ioannou, G.N. Yongvanit, P. |
2013 |
Journal of Steroid Biochemistry and Molecular Biology (138), pp. 368-375 |
||||||||
| 6. | Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers | Chan-On, W. Dima, S.O.L. Pairojkul, C. Lim, K. McPherson, J.R. Cutcutache, I. Heng, H. Choo, S. Tan, I.B.H. Myint, S.S. Wong, B. Rajasegaran, V. Ng, C.C.Y. Jusakul, A. Huang, D. Sithithaworn, P. Yongvanit, P. Wongkham, S. Khuntikeo, N. Bhudhisawasdi, V. |
2013 |
Nature Genetics 12 (45), pp. 1474-1478 |
||||||||
| 7. | Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression | Khenjanta, C. Thanan, R. Jusakul, A. Techasen, A. Jamnongkan, W. Namwat, N. Loilome, W. Pairojkul, C. Yongvanit, P. |
2014 |
Asian Pacific Journal of Cancer Prevention 23 (15), pp. 10187-10192 |
||||||||
| 8. | Genetics of Opisthorchis viverrini -related cholangiocarcinoma | Jusakul, A. Kongpetch, S. |
2015 |
Current Opinion in Gastroenterology 3 (31), pp. 258-263 |
||||||||
| 9. | Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways | Kongpetch, S. Jusakul, A. Ong, C. Lim, W. |
2015 |
Best Practice and Research: Clinical Gastroenterology 2 (29), pp. 233-244 |
||||||||
| 10. | Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma | Jusakul, A. Choo, S. Lim, K. Ong, C. Dima, S.O.L. Wongkham, C. Yongvanit, P. Wongkham, S. Bhudhisawasdi, V. Khuntikeo, N. Pairojkul, C. Nagarajan, N.S. |
2016 |
EBioMedicine (8), pp. 195-202 |
||||||||
| 11. | Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand | Senggunprai, L. Namwat, N. Kongpetch, S. Chamgramol, Y. Loilome, W. Khansaard, W. Jusakul, A. Prawan, A. Pairojkul, C. Yongvanit, P. Kukongviriyapan, V. |
2017 |
Tumor Biology 11 (39), pp. |
||||||||
| 12. | Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma | Jusakul, A. Cutcutache, I. Kongpetch, S. Myint, S.S. Thanan, R. Ng, C.C.Y. Rajasegaran, V. McPherson, J.R. Khuntikeo, N. Bhudhisawasdi, V. Yongvanit, P. Dima, S.O.L. Shibata, T. Pairojkul, C. |
2017 |
Cancer Discovery 10 (7), pp. 1116-1135 |
||||||||
| 13. | Current omics-based biomarkers for cholangiocarcinoma | Intuyod, K. Armartmuntree, N. Jusakul, A. Sakonsinsiri, C. Thanan, R. Pinlaor, S. |
2019 |
Expert Review of Molecular Diagnostics 11 (19), pp. 997-1005 |
||||||||
| 14. | A combination of monosodium glutamate and high-fat and high-fructose diets increases the risk of kidney injury, gut dysbiosis and host-microbial co-metabolism | Haonon, O. Onsurathum, S. Jusakul, A. Intuyod, K. Sangka, A. Anutrakulchai, S. Cha'on, U. Pinlaor, S. Pinlaor, P. |
2020 |
PLoS ONE 4 (15), pp. |
||||||||
| 15. | ARID1A alterations and their clinical significance in cholangiocarcinoma | Techasen, A. Loilome, W. Jusakul, A. |
2020 |
PeerJ (8), pp. |
||||||||
| 16. | Circulating TGF-β1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma | Jusakul, A. Junsawang, P. Loilome, W. Khuntikeo, N. Techasen, A. |
2020 |
Journal of Gastrointestinal Oncology 2 (11), pp. 304-318 |
||||||||
| 17. | Lack of targetable FGFR2 fusions in endemic fluke-associated cholangiocarcinoma | Kongpetch, S. Jusakul, A. Ng, C.C.Y. Rajasegaran, V. Dima, S.O.L. Kukongviriyapan, V. Khuntikeo, N. Pairojkul, C. |
2020 |
JCO Global Oncology (6), pp. 628-638 |
||||||||
| 18. | Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma | Proungvitaya, T. Limpaiboon, T. Jusakul, A. Titapun, A. Patrakitkomjorn, S. |
2020 |
Oncology Letters 1 (19), pp. 930-942 |
||||||||
| 19. | Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway | Jusakul, A. Kongpetch, S. Kimawaha, P. Klanrit, P. Loilome, W. Namwat, N. Techasen, A. |
2021 |
Naunyn-Schmiedeberg's Archives of Pharmacology 10 (394), pp. 2049-2059 |
||||||||
| 20. | Diagnostic and prognostic value of circulating cell‐free dna for cholangiocarcinoma | Wintachai, P. Techasen, A. Lert-Itthiporn, W. Kongpetch, S. Loilome, W. Titapun, A. Namwat, N. Khuntikeo, N. Jusakul, A. |
2021 |
Diagnostics 6 (11), pp. |
||||||||
| 21. | Establishment of a potential serum biomarker panel for the diagnosis and prognosis of cholangiocarcinoma using decision tree algorithms | Kimawaha, P. Jusakul, A. Junsawang, P. Thanan, R. Titapun, A. Khuntikeo, N. Techasen, A. |
2021 |
Diagnostics 4 (11), pp. |
||||||||
| 22. | Promoter hypermethylation of early B cell factor 1 (EBF1) is associated with cholangiocarcinoma progression | Armartmuntree, N. Jusakul, A. Sakonsinsiri, C. Loilome, W. Pinlaor, S. Ungarreevittaya, P. Techasen, A. Imtawil, K.J. Kraiklang, R. Suwannakul, N. Thanan, R. |
2021 |
Journal of Cancer 9 (12), pp. 2673-2686 |
||||||||
| 23. | Vitamin C supplementation reduces expression of circulating miR-451a in subjects with poorly controlled type 2 diabetes mellitus and high oxidative stress | Jumnainsong, A. Leelayuwat, N. Jusakul, A. Leelayuwat, C. |
2021 |
PeerJ (9), pp. |
||||||||
| 24. | Concentration of Urine Samples Improves Sensitivity in Detection of Strongyloides-Specific IgG Antibody in Urine for Diagnosis of Strongyloidiasis | Sithithaworn, P. Worasith, C. Wongphutorn, P. Kopolrat, K.Y. Jusakul, A. Thanan, R. Duenngai, K. Sithithaworn, J. Techasen, A. |
2022 |
Journal of clinical microbiology 1 (60), pp. e0145421 |
||||||||
| 25. | Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways | Jaidee, R. Kukongviriyapan, V. Senggunprai, L. Prawan, A. Jusakul, A. Laphanuwat, P. Kongpetch, S. |
2022 |
Life Sciences (296), pp. |
||||||||
| 26. | Prediction of Angiopoietin-like Protein 4-related Signaling Pathways in Cholangiocarcinoma Cells | Aung, T.M. Silsirivanit, A. Jusakul, A. Chan-On, W. Proungvitaya, T. Roytrakul, S. Proungvitaya, S. |
2022 |
Cancer Genomics and Proteomics 4 (19), pp. 490-502 |
||||||||
| 27. | Serum Angiopoietin-Like Protein 4: A Potential Prognostic Biomarker for Prediction of Vascular Invasion and Lymph Node Metastasis in Cholangiocarcinoma Patients | Silsirivanit, A. Jusakul, A. Lert-Itthiporn, W. Proungvitaya, T. Patrakitkomjorn, S. |
2022 |
Frontiers in Public Health (10), pp. |
||||||||
| 28. | Therapeutic targeting of ARID1A and PI3K/AKT pathway alterations in cholangiocarcinoma | Techasen, A. Kongpetch, S. Namjan, A. Loilome, W. Chan-On, W. Thanan, R. Jusakul, A. |
2022 |
PeerJ (10), pp. |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Mechanisms of oxysterol-induced carcinogenesis. | Jusakul, A Yongvanit, P Loilome, W Namwat, N Kuver, R |
2011 |
Lipids in health and disease (10), pp. 44 |
|
| 2. | Identification of biliary bile acids in patients with benign biliary diseases, hepatocellular carcinoma and cholangiocarcinoma. | Jusakul, A Khuntikeo, N Haigh, WG Kuver, R Ioannou, GN Loilome, W Namwat, N Bhudhisawasdi, V Pugkhem, A Pairojkul, C Yongvanit, P |
2012 |
Asian Pacific journal of cancer prevention : APJCP (13), pp. 77-82 |
|
| 3. | Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: a potential molecular marker for tumor metastasis. | Loilome, W Wechagama, P Namwat, N Jusakul, A Sripa, B Miwa, M Kuver, R Yongvanit, P |
2012 |
Parasitology international 1 (61), pp. 136-9 |
|
| 4. | Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes. | Jusakul, A Loilome, W Namwat, N Haigh, WG Kuver, R Dechakhamphu, S Sukontawarin, P Pinlaor, S Lee, SP Yongvanit, P |
2012 |
Mutation research 1 (731), pp. 48-57 |
|
| 5. | Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers. | Chan-On, W Nairismägi, ML Ong, CK Lim, WK Dima, S Pairojkul, C Lim, KH McPherson, JR Cutcutache, I Heng, HL Ooi, L Chung, A Chow, P Cheow, PC Lee, SY Choo, SP Tan, IB Duda, D Nastase, A Myint, SS Wong, BH Gan, A Rajasegaran, V Ng, CC Nagarajan, S Jusakul, A Zhang, S Vohra, P Yu, W Huang, D Sithithaworn, P Yongvanit, P Wongkham, S Khuntikeo, N Bhudhisawasdi, V Popescu, I Rozen, SG Tan, P Teh, BT |
2013 |
Nature genetics 12 (45), pp. 1474-8 |
|
| 6. | Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol-resistant human cholangiocytes: characteristics contributing to the genesis of cholangiocarcinoma. | Jusakul, A Loilome, W Namwat, N Techasen, A Kuver, R Ioannou, GN Savard, C Haigh, WG Yongvanit, P |
2013 |
The Journal of steroid biochemistry and molecular biology (138), pp. 368-75 |
|
| 7. | Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression. | Khenjanta, C Thanan, R Jusakul, A Techasen, A Jamnongkan, W Namwat, N Loilome, W Pairojkul, C Yongvanit, P |
2014 |
Asian Pacific journal of cancer prevention : APJCP 23 (15), pp. 10187-92 |
|
| 8. | Genetics of Opisthorchis viverrini-related cholangiocarcinoma. | Jusakul, A Kongpetch, S Teh, BT |
2015 |
Current opinion in gastroenterology 3 (31), pp. 258-63 |
|
| 9. | Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways. | Kongpetch, S Jusakul, A Ong, CK Lim, WK Rozen, SG Tan, P Teh, BT |
2015 |
Best practice & research. Clinical gastroenterology 2 (29), pp. 233-44 |
|
| 10. | Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma. | Chng, KR Chan, SH Ng, AH Li, C Jusakul, A Bertrand, D Wilm, A Choo, SP Tan, DM Lim, KH Soetinko, R Ong, CK Duda, DG Dima, S Popescu, I Wongkham, C Feng, Z Yeoh, KG Teh, BT Yongvanit, P Wongkham, S Bhudhisawasdi, V Khuntikeo, N Tan, P Pairojkul, C Ngeow, J Nagarajan, N |
2016 |
EBioMedicine (8), pp. 195-202 |
|
| 11. | Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma. | Jusakul, A Cutcutache, I Yong, CH Lim, JQ Huang, MN Padmanabhan, N Nellore, V Kongpetch, S Ng, AWT Ng, LM Choo, SP Myint, SS Thanan, R Nagarajan, S Lim, WK Ng, CCY Boot, A Liu, M Ong, CK Rajasegaran, V Lie, S Lim, AST Lim, TH Tan, J Loh, JL McPherson, JR Khuntikeo, N Bhudhisawasdi, V Yongvanit, P Wongkham, S Totoki, Y Nakamura, H Arai, Y Yamasaki, S Chow, PK Chung, AYF Ooi, LLPJ Lim, KH Dima, S Duda, DG Popescu, I Broet, P Hsieh, SY Yu, MC Scarpa, A Lai, J Luo, DX Carvalho, AL Vettore, AL Rhee, H Park, YN Alexandrov, LB Gordân, R Rozen, SG Shibata, T Pairojkul, C Teh, BT Tan, P |
2017 |
Cancer discovery 10 (7), pp. 1116-1135 |
|
| 12. | Current omics-based biomarkers for cholangiocarcinoma. | Intuyod, K Armartmuntree, N Jusakul, A Sakonsinsiri, C Thanan, R Pinlaor, S |
2019 |
Expert review of molecular diagnostics (), pp. 1-9 |
|
| 13. | alterations and their clinical significance in cholangiocarcinoma. | Namjan, A Techasen, A Loilome, W Sa-Ngaimwibool, P Jusakul, A |
2020 |
PeerJ (8), pp. e10464 |
|
| 14. | Circulating TGF-β1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma. | Kimawaha, P Jusakul, A Junsawang, P Loilome, W Khuntikeo, N Techasen, A |
2020 |
Journal of gastrointestinal oncology 2 (11), pp. 304-318 |
|
| 15. | Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma. | Kongpetch, S Jusakul, A Lim, JQ Ng, CCY Chan, JY Rajasegaran, V Lim, TH Lim, KH Choo, SP Dima, S Popescu, I Duda, DG Kukongviriyapan, V Khuntikeo, N Pairojkul, C Rozen, SG Tan, P Teh, BT |
2020 |
JCO global oncology (6), pp. 628-638 |
|
| 16. | A combination of monosodium glutamate and high-fat and high-fructose diets increases the risk of kidney injury, gut dysbiosis and host-microbial co-metabolism. | Pongking, T Haonon, O Dangtakot, R Onsurathum, S Jusakul, A Intuyod, K Sangka, A Anutrakulchai, S Cha'on, U Pinlaor, S Pinlaor, P |
2020 |
PloS one 4 (15), pp. e0231237 |
|
| 17. | Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma. | Chanakankun, R Proungvitaya, T Chua-On, D Limpaiboon, T Roytrakul, S Jusakul, A Titapun, A Jarearnrat, A Proungvitaya, S |
2020 |
Oncology letters 1 (19), pp. 930-942 |
|
| 18. | Vitamin C supplementation reduces expression of circulating miR-451a in subjects with poorly controlled type 2 diabetes mellitus and high oxidative stress. | Ruknarong, L Boonthongkaew, C Chuangchot, N Jumnainsong, A Leelayuwat, N Jusakul, A Gaudieri, S Leelayuwat, C |
2021 |
PeerJ (9), pp. e10776 |
|
| 19. | Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway. | Janthamala, S Jusakul, A Kongpetch, S Kimawaha, P Klanrit, P Loilome, W Namwat, N Techasen, A |
2021 |
Naunyn-Schmiedeberg's archives of pharmacology 10 (394), pp. 2049-2059 |
|
| 20. | Concentration of urine samples improves sensitivity in detection of -specific IgG antibody in urine for diagnosis of strongyloidiasis. | Chungkanchana, N Sithithaworn, P Worasith, C Wongphutorn, P Ruantip, S Kopolrat, KY Jusakul, A Thanan, R Duenngai, K Sithithaworn, J Techasen, A |
2021 |
Journal of clinical microbiology (), pp. JCM0145421 |
|
| 21. | Promoter hypermethylation of early B cell factor 1 (EBF1) is associated with cholangiocarcinoma progression. | Armartmuntree, N Jusakul, A Sakonsinsiri, C Loilome, W Pinlaor, S Ungarreevittaya, P Yong, CH Techasen, A Imtawil, K Kraiklang, R Suwannakul, N Kaewlert, W Chaiprasert, T Thanan, R Murata, M |
2021 |
Journal of Cancer 9 (12), pp. 2673-2686 |
|
| 22. | Serum Angiopoietin-Like Protein 4: A Potential Prognostic Biomarker for Prediction of Vascular Invasion and Lymph Node Metastasis in Cholangiocarcinoma Patients. | Aung, TM Ciin, MN Silsirivanit, A Jusakul, A Lert-Itthiporn, W Proungvitaya, T Roytrakul, S Proungvitaya, S |
2022 |
Frontiers in public health (10), pp. 836985 |
|
| 23. | Therapeutic targeting of ARID1A and PI3K/AKT pathway alterations in cholangiocarcinoma. | Tessiri, S Techasen, A Kongpetch, S Namjan, A Loilome, W Chan-On, W Thanan, R Jusakul, A |
2022 |
PeerJ (10), pp. e12750 |
|
| 24. | Prediction of Angiopoietin-like Protein 4-related Signaling Pathways in Cholangiocarcinoma Cells. | Aung, TM Silsirivanit, A Jusakul, A Chan-On, W Proungvitaya, T Roytrakul, S Proungvitaya, S |
2022 |
Cancer genomics & proteomics 4 (19), pp. 490-502 |
|
| 25. | Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways. | Jaidee, R Kukongviriyapan, V Senggunprai, L Prawan, A Jusakul, A Laphanuwat, P Kongpetch, S |
2022 |
Life sciences (), pp. 120427 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | Total | ||||||
| 1. | Mechanisms of oxysterol-induced carcinogenesis | Apinya Jusakul Puangrat Yongvanit Watcharin Loilome Nisana Namwat Rahul Kuver |
2011 |
LIPIDS IN HEALTH AND DISEASE (10.0), pp. |
58 | 0 | 0 | 0 | 0 | 0 | 58 | |
| 2. | Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: A potential molecular marker for tumor metastasis | Watcharin Loilome Pairoj Wechagama Nisana Namwat Apinya Jusakul Banchob Sripa Masanao Miwa Rahul Kuver Puangrat Yongvanit |
2012 |
PARASITOLOGY INTERNATIONAL 1.0 (61.0), pp. 136.0-139.0 |
23 | 0 | 0 | 0 | 0 | 0 | 23 | |
| 3. | Identification of Biliary Bile Acids in Patients with Benign Biliary Diseases, Hepatocellular Carcinoma and Cholangiocarcinoma | Apinya Jusakul Narong Khuntikeo W. Geoffrey Haigh Rahul Kuver George N. Ioannou Watcharin Loilome Nisana Namwat Vajarabhongsa Bhudhisawasdi Ake Pugkhem Chawalit Pairojkul Puangrat Yongvanit |
2012 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (13.0), pp. 77.0-82.0 |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 4. | Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes | Apinya Jusakul Watcharin Loilome Nisana Namwat W. Geoffrey Haigh Rahul Kuver Somkid Dechakhamphu Pradit Sukontawarin Somchai Pinlaor Sum P. Lee Puangrat Yongvanit |
2012 |
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS 1-2 (731.0), pp. 48.0-57.0 |
34 | 0 | 0 | 0 | 0 | 0 | 34 | |
| 5. | Anti-apoptotic phenotypes of cholestan-3 beta,5 alpha,6 beta-triol-resistant human cholangiocytes: Characteristics contributing to the genesis of cholangiocarcinoma | Apinya Jusakul Watcharin Loilome Nisana Namwat Anchalee Techasen Rahul Kuver George N. Ioannou Christopher Savard W. Geoffrey Haigh Puangrat Yongvanit |
2013 |
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (138.0), pp. 368.0-375.0 |
14 | 0 | 0 | 0 | 0 | 0 | 14 | |
| 6. | Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers | Waraporn Chan-on Maarja-Liisa Nairismaegi Choon Kiat Ong Weng Khong Lim Simona Dima Chawalit Pairojkul Kiat Hon Lim John R. McPherson Ioana Cutcutache Hong Lee Heng London Ooi Alexander Chung Pierce Chow Peng Chung Cheow Ser Yee Lee Su Pin Choo Iain Bee Huat Tan Dan Duda Anca Nastase Swe Swe Myint Bernice Huimin Wong Anna Gan Vikneswari Rajasegaran Cedric Chuan Young Ng Sanjanaa Nagarajan Apinya Jusakul Shenli Zhang Priya Vohra Willie Yu DaChuan Huang Paiboon Sithithaworn Puangrat Yongvanit Sopit Wongkham Narong Khuntikeo Vajaraphongsa Bhudhisawasdi Irinel Popescu Steven G. Rozen Patrick Tan Bin Tean Teh |
2013 |
NATURE GENETICS 12.0 (45.0), pp. 1474.0-U100 |
247 | 0 | 0 | 0 | 0 | 0 | 247 | |
| 7. | Association of CYP39A1, RUNX2 and Oxidized Alpha-1 Antitrypsin Expression in Relation to Cholangiocarcinoma Progression | Chakkaphan Khenjanta Raynoo Thanan Apinya Jusakul Anchalee Techasen Wassana Jamnongkan Nisana Namwat Watcharin Loilome Chawalit Pairojkul Puangrat Yongvanit |
2014 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION 23.0 (15.0), pp. 10187.0-10192.0 |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| 8. | Genetics of Opisthorchis viverrini-related cholangiocarcinoma | Apinya Jusakul Sarinya Kongpetch Bin Tean Teh |
2015 |
CURRENT OPINION IN GASTROENTEROLOGY 3.0 (31.0), pp. 258.0-263.0 |
38 | 0 | 0 | 0 | 0 | 0 | 38 | |
| 9. | Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways | Sarinya Kongpetch Apinya Jusakul Choon Kiat Ong Weng Khong Lim Steven G. Rozen Patrick Tan Bin Tean Teh |
2015 |
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY 2.0 (29.0), pp. 233.0-244.0 |
36 | 0 | 0 | 0 | 0 | 0 | 36 | |
| 10. | Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma | Kern Rei Chng Sock Hoai Chan Amanda Hui Qi Ng Chenhao Li Apinya Jusakul Denis Bertrand Andreas Wilm Su Pin Choo Damien Meng Yew Tan Kiat Hon Lim Roy Soetinko Choon Kiat Ong Dan G. Duda Simona Dima Irinel Popescu Chaisiri Wongkham Zhu Feng Khay Guan Yeoh Bin Tean Teh Puangrat Yongvanit Sopit Wongkham Vajaraphongsa Bhudhisawasd Narong Khuntikeo Patrick Tan Chawalit Pairojkul Joanne Ngeow Niranjan Nagarajan |
2016 |
EBIOMEDICINE (8.0), pp. 195.0-202.0 |
53 | 0 | 0 | 0 | 0 | 0 | 53 | |
| 11. | TGF- beta 1: A Potential EMT-Biomarker for prediction of cholangiocarcinoma | Phongsaran Kimawaha Apinya Jusakul Puangrat Yongvanit Watcharin Loilome Nisana Namwat Narong Khuntikeo Anchalee Techasen |
2018 |
CANCER SCIENCE (109.0), pp. 956.0-956.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 12. | Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma | Apinya Jusakul Ioana Cutcutache Chern Han Yong Jing Quan Lim Mi Ni Huang Nisha Padmanabhan Vishwa Nellore Sarinya Kongpetch Alvin Wei Tian Ng Ley Moy Ng Su Pin Choo Swe Swe Myint Raynoo Thanan Sanjanaa Nagarajan Weng Khong Lim Cedric Chuan Young Ng Arnoud Boot Mo Liu Choon Kiat Ong Vikneswari Rajasegaran Stefanus Lie Alvin Soon Tiong Lim Tse Hui Lim Jing Tan Jia Liang Loh John R. McPherson Narong Khuntikeo Vajaraphongsa Bhudhisawasdi Puangrat Yongvanit Sopit Wongkham Yasushi Totoki Hiromi Nakamura Yasuhito Arai Satoshi Yamasaki Pierce Kah-Hoe Chow Alexander Yaw Fui Chung London Lucien Peng Jin Ooi Kiat Hon Lim Simona Dima Dan G. Duda Irinel Popescu Philippe Broet Sen-Yung Hsieh Ming-Chin Yu Aldo Scarpa Jiaming Lai Di-Xian Luo Andre Lopes Carvalho Andre Luiz Vettore Hyungjin Rhee Young Nyun Park Ludmil B. Alexandrov Raluca Gordan Steven G. Rozen Tatsuhiro Shibata Chawalit Pairojkul Bin Tean Teh Patrick Tan |
2018 |
CANCER SCIENCE (109.0), pp. 720.0-720.0 |
243 | 0 | 0 | 0 | 0 | 0 | 243 | |
| 13. | Current omics-based biomarkers for cholangiocarcinoma | Kitti Intuyod Napat Armartmuntree Apinya Jusakul Chadamas Sakonsinsiri Raynoo Thanan Somchai Pinlaor |
2019 |
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS 11.0 (19.0), pp. 997.0-1005.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 14. | A combination of monosodium glutamate and high-fat and high-fructose diets increases the risk of kidney injury, gut dysbiosis and host-microbial co-metabolism | Thatsanapong Pongking Ornuma Haonon Rungtiwa Dangtakot Sudarat Onsurathum Apinya Jusakul Kitti Intuyod Arunnee Sangka Sirirat Anutrakulchai Ubon Cha'on Somchai Pinlaor Porntip Pinlaor |
2020 |
PLOS ONE 4.0 (15.0), pp. |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 15. | ARID1A alterations and their clinical significance in cholangiocarcinoma | Achira Namjan Anchalee Techasen Watcharin Loilome Prakasit Sa-ngairnwibool Apinya Jusakul |
2020 |
PEERJ (8.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 16. | Circulating TGF-beta 1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma | Phongsaran Kimawaha Apinya Jusakul Prem Junsawang Watcharin Loilome Narong Khuntikeo Anchalee Techasen |
2020 |
JOURNAL OF GASTROINTESTINAL ONCOLOGY 2.0 (11.0), pp. 304.0-318.0 |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 17. | Enhancement of vitamin C on PMN function in healthy individuals | Laongthip Ruknarong Rujira Nonsa-ard Nisa Chuangchot Amonrat Jumnainsong Naruemon Leelayuwat Apinya Jusakul Chanvit Leelayuwat |
2020 |
JOURNAL OF IMMUNOLOGY 1.0 (204.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 18. | Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma | Sarinya Kongpetch Apinya Jusakul Jing Quan Lim Cedric Chuan Young Ng Jason Yongsheng Chan Vikneswari Rajasegaran Tse Hui Lim Kiat Hon Lim Su Pin Choo Simona Dima Irinel Popescu Dan G. Duda Veerapol Kukongviriyapan Narong Khuntikeo Chawalit Pairojkul Steven G. Rozen Patrick Tan Bin Tean Teh |
2020 |
JCO GLOBAL ONCOLOGY (6.0), pp. 628.0-638.0 |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 19. | Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma | Ravinnipa Chanakankun Tanakorn Proungvitaya Daraporn Chua-On Temduang Limpaiboon Sittiruk Roytrakul Apinya Jusakul Attapol Titapun Apiwat Jarearnrat Siriporn Proungvitaya |
2020 |
ONCOLOGY LETTERS 1.0 (19.0), pp. 930.0-942.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 20. | Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway | Sutthiwan Janthamala Apinya Jusakul Sarinya Kongpetch Phongsaran Kimawaha Poramate Klanrit Watcharin Loilome Nisana Namwat Anchalee Techasen |
2021 |
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 10.0 (394.0), pp. 2049.0-2059.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 21. | Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma | Preawwalee Wintachai Jing Quan Lim Anchalee Techasen Worachart Lert-Itthiporn Sarinya Kongpetch Watcharin Loilome Jarin Chindaprasirt Attapol Titapun Nisana Namwat Narong Khuntikeo Apinya Jusakul |
2021 |
DIAGNOSTICS 6.0 (11.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 22. | Establishment of a Potential Serum Biomarker Panel for the Diagnosis and Prognosis of Cholangiocarcinoma Using Decision Tree Algorithms | Phongsaran Kimawaha Apinya Jusakul Prem Junsawang Raynoo Thanan Attapol Titapun Narong Khuntikeo Anchalee Techasen |
2021 |
DIAGNOSTICS 4.0 (11.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 23. | Promoter hypermethylation of early B cell factor 1 (EBF1) is associated with cholangiocarcinoma progression | Napat Armartmuntree Apinya Jusakul Chadamas Sakonsinsiri Watcharin Loilome Somchai Pinlaor Piti Ungarreevittaya Chern Han Yong Anchalee Techasen Kanokwan Imtawil Ratthaphol Kraiklang Nattawan Suwannakul Waleeporn Kaewlert Timpika Chaiprasert Raynoo Thanan Mariko Murata |
2021 |
JOURNAL OF CANCER 9.0 (12.0), pp. 2673.0-2686.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 24. | Vitamin C supplementation reduces expression of circulating miR-451a in subjects with poorly controlled type 2 diabetes mellitus and high oxidative stress | Laongthip Ruknarong Chongchira Boonthongkaew Nisa Chuangchot Amonrat Jumnainsong Naruemon Leelayuwat Apinya Jusakul Silvana Gaudieri Chanvit Leelayuwat |
2021 |
PEERJ (9.0), pp. |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| Title | Authors | Year | Journal title |
|---|
| Title | Authors | NRIIS type | Year | NRIIS Scholarship |
|---|